China Biotech Week in Review: Year-End IPOs
At the beginning of 2009, IPO activity was at a standstill. But as the year progressed, and the threat of a complete financial disaster receded, a few companies managed to complete transactions that made them publicly owned entities, including several representatives of the China life science sector. We looked at how they fared, noticing a [...]
China Nuokang Bio-Pharmaceutical Inc. Announces Pricing of Initial Public Offering on the NASDAQ Global Market
Beijing, China, December 9, 2009 – China Nuokang Bio-Pharmaceutical Inc. (NASDAQ: NKBP) (“Nuokang” or the “Company”), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products, announced today that its initial public offering of 5,000,000 American Depositary Shares (“ADSs”), each representing eight ordinary shares of the [...]
China Trials 2009